Electrophysiological properties and chemosensitivity of acutely dissociated trigeminal somata innervating the cornea.
Adult rat sensory trigeminal ganglion neurons innervating the cornea (cTGNs) were isolated and identified following retrograde dye labeling with FM1-43. Using standard whole-cell patch clamp recording techniques, cTGNs could be subdivided by their action potential (AP) duration. Fast cTGNs had AP durations <1 ms (40%) while slow cTGNs had AP durations >1 ms and an inflection on the repolarization phase of the AP. With the exception of membrane input resistance, the passive membrane properties of fast cTGNs were different from those of slow cTGNs (capacitance: 61+/-4.5 pF vs. 42+/-2.6 pF, resting membrane potential: -59+/-0.7 mV vs. -53+/-0.9 mV, for fast and slow cTGNs respectively). Active membrane properties also differed between fast and slow cTGNs. Slow cTGNs had a higher AP threshold (-25+/-1.6 mV vs. -38+/-0.8 mV), a larger rheobase (14+/-1.9 pA/pF vs. 6.8+/-1.0 pA/pF), and a smaller AP undershoot (-56+/-1.7 mV vs. -67+/-2.5 mV). The AP overshoot, however was similar between the two types of neurons (46+/-3.1 mV vs. 48+/-4 mV). Slow cTGNs were depolarized by capsaicin (1 microM, 80%) and 60% of their APs were blocked by tetrodotoxin (TTX) (100 nM). Fast cTGNs were unaffected by capsaicin and 100% of their APs were blocked by TTX. Similarly, cTGNs were also heterogeneous with respect to their responses to exogenous ATP and 5-HT. The current work shows that cTGNs have distinctive electrophysiological properties and chemosensitivity profiles. These characteristics may mirror the distinct properties of corneal sensory nerve terminals. The availability of isolated identified cTGNs constitutes a tractable model system to investigate the biophysical and pharmacological properties of corneal sensory nerve terminals.
Veiga Moreira
T H
TH
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, USA.
Gover
T D
TD
Weinreich
D
D
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D002478:Cells, Cultured; D003315:Cornea / Q000294:innervation* / Q000502:physiology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology*; D009882:Ophthalmic Nerve / Q000187:drug effects / Q000502:physiology*; D010146:Pain / Q000503:physiopathology; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D051381:Rats; D017207:Rats, Sprague-Dawley; D026941:Sodium Channel Blockers / Q000494:pharmacology; D012668:Trigeminal Ganglion / Q000187:drug effects / Q000502:physiology*
C073804:FM1 43; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D026941:Sodium Channel Blockers; D002211:Capsaicin
J Physiol. 2005 Jun 15;565(Pt 3):927-43
15831536
J Pharmacol Exp Ther. 2005 Jul;314(1):437-45
15831438
Cell Calcium. 2007 Apr;41(4):389-96
17046058
Brain Res Mol Brain Res. 1999 Dec 10;74(1-2):55-68
10640676
Neuroscience. 2000;101(4):1109-15
11113359
Annu Rev Physiol. 2001;63:871-94
11181979
Prog Neurobiol. 2001 Oct;65(2):107-34
11403876
Cephalalgia. 2002 Jul;22(6):424-31
12133041
Exp Eye Res. 2003 May;76(5):521-42
12697417
J Neurosci. 2003 May 15;23(10):4054-65
12764092
Life Sci. 2003 Jul 18;73(9):1175-87
12818725
J Neurosci. 2003 Jun 15;23(12):4793-7
12832498
J Physiol. 2003 Aug 1;550(Pt 3):739-52
12794175
J Neurosci. 2003 Nov 12;23(32):10338-50
14614093
J Neurosci. 2003 Nov 26;23(34):10988-97
14645495
Neurosci Lett. 1981 May 29;23(3):243-9
6167911
Neurosci Lett. 1984 Nov 23;52(1-2):117-22
6527829
Invest Ophthalmol Vis Sci. 1989 Mar;30(3):461-72
2494126
J Neurosci Methods. 1990 Jun;32(3):213-22
2385139
J Physiol. 1991 Jun;437:709-25
1890657
J Comp Neurol. 1991 Nov 1;313(1):132-50
1761750
Neuroscience. 1993 Jul;55(2):521-9
7690911
J Neurosci. 1993 Oct;13(10):4511-24
8410200
Br J Pharmacol. 1997 Feb;120(3):469-75
9031751
J Neurophysiol. 1997 Dec;78(6):3198-209
9405539
Cephalalgia. 1997 Dec;17(8):833-42
9453271
J Appl Physiol (1985). 1998 Jul;85(1):123-8
9655764
Eur J Neurosci. 1998 Nov;10(11):3470-8
9824460
Annu Rev Neurosci. 1999;22:443-85
10202545
Arch Histol Cytol. 1999 May;62(2):129-38
10399537
Neuroscience. 1999;93(2):713-22
10465455
Neurosci Lett. 2005 Aug 26;384(3):294-9
15908117